$22.19
0[0.00%]
At close: May 13
$22.19
0[0.00%]
PreMarket: 4:08PM EDT
Fulgent Genetics
(NASDAQ:FLGT)Latest News for Fulgent Genetics Stock (NASDAQ:FLGT)
Fulgent Genetics Stock (NASDAQ: FLGT)
Categories: All
Friday, May 03, 2024
- Fulgent Forecasts 2024 Core Revenue Of Approximately $280M Versus Consensus Of $279.356M, With Adjusted EPS Loss Of Approximately $(1.05) Versus Consensus Of $(1.06)Benzinga Newsdesk - May 3, 2024, 7:05AM
- Fulgent Genetics Q1 2024 Adj EPS $(0.01) May Not Be Comparable To $(0.32) Estimate, Sales $64.485M Miss $65.363M EstimateBenzinga Newsdesk - May 3, 2024, 7:02AM
Wednesday, March 06, 2024
Wednesday, February 28, 2024
- Fulgent Genetics shares are trading lower after the company reported Q4 financial results and issued FY24 guidance below estimates.Benzinga Newsdesk - Feb 28, 2024, 12:07PM
- Fulgent Genetics Expects 2024 Core Revenue of Approximately $280M Versus Consensus Of $294.25M, With Adjusted EPS Loss Of Approximately $(1.05) Versus Consensus Of $(0.95)Benzinga Newsdesk - Feb 28, 2024, 7:05AM
- Fulgent Genetics Q4 Adjusted EPS $0.28 May Not Be Comparable To $(0.29) Estimate, Sales $70.50M Beat $66.32M EstimateBenzinga Newsdesk - Feb 28, 2024, 7:02AM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Friday, February 09, 2024
Thursday, December 07, 2023
Friday, November 03, 2023
- Fulgent Genetics shares are trading higher after the company reported better-than-expected Q3 revenue results and issued FY23 guidance.Benzinga Newsdesk - Nov 3, 2023, 12:27PM
- Fulgent Sees FY23 Core Revenue $260M Vs $260.66M Estimate, Adj. EPS $(0.95) Vs $(1.09) EstimateBenzinga Newsdesk - Nov 3, 2023, 7:27AM
- Earnings Scheduled For November 3, 2023Benzinga Insights - Nov 3, 2023, 7:12AM
- Fulgent Q3 2023 EPS $(0.39) Misses $(0.33) Estimate, Revenue $66M Beats $63.4M EstimateBenzinga Newsdesk - Nov 3, 2023, 7:04AM
Thursday, November 02, 2023
Monday, October 16, 2023
Wednesday, October 04, 2023
Monday, October 02, 2023
Friday, September 29, 2023
Thursday, September 28, 2023
Thursday, September 21, 2023
Friday, August 04, 2023
- Why Is Fulgent Genetics Stock Moving Higher Today?Vandana Singh - Aug 4, 2023, 1:20PM
- Fulgent Sees Q3 FY23 Sales Of Approximately $65M Vs. Consensus Of $62.84MBenzinga Newsdesk - Aug 4, 2023, 7:11AM
- Fulgent Revises FY23 Revenue Guidance To $260M Vs. Consensus Of $255.94M And Prior Guidance Of $250M, It Forecasts Adjusted EPS Of $(0.95) Vs. Consensus Of $(1.23) And Prior Guidance Of $(1.25)Benzinga Newsdesk - Aug 4, 2023, 7:10AM
- Fulgent Genetics Q2 Adjusted EPS $(0.08) Beats $(0.33) Estimate, Sales $67.85M Beat $62.68M EstimateBenzinga Newsdesk - Aug 4, 2023, 7:01AM
- Earnings Scheduled For August 4, 2023Benzinga Insights - Aug 4, 2023, 5:30AM
Thursday, August 03, 2023
Friday, May 19, 2023
Friday, May 05, 2023
- Fulgent Genetics shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results.Benzinga Newsdesk - May 5, 2023, 11:18AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - May 5, 2023, 9:06AM
- Fulgent Genetics: Q1 Earnings InsightsBenzinga Insights - May 5, 2023, 7:05AM
- Fulgent Genetics Q1 Adjusted EPS $(0.22) Beats $(0.43) Estimate, Sales $66.17M Beat $60.05M EstimateBenzinga Newsdesk - May 5, 2023, 7:05AM
- Earnings Scheduled For May 5, 2023Benzinga Insights - May 5, 2023, 5:59AM
Thursday, May 04, 2023
Monday, April 03, 2023
Monday, March 06, 2023
Thursday, March 02, 2023
Tuesday, February 28, 2023
- Fulgent Genetics Sees Q1 Total Revenue $56M vs $60.92M Est.; Sees FY23 Adj. EPS $(1.25) vs $(2.18) Est., Total Revenue ~$240M vs $260.75M Est.Bill Haddad - Feb 28, 2023, 4:52PM
- Fulgent Genetics Q4 EPS $(0.48) Beats $(0.56) Estimate, Sales $67.70M Beat $59.57M EstimateBill Haddad - Feb 28, 2023, 4:51PM
- Earnings Scheduled For February 28, 2023Benzinga Insights - Feb 28, 2023, 4:34AM
Friday, January 06, 2023
Tuesday, December 20, 2022
Monday, December 19, 2022
Thursday, December 08, 2022
- Fulgent Genetics, Inc. shares are trading lower after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $65 to $40.Benzinga Newsdesk - Dec 8, 2022, 11:51AM
- Where Fulgent Genetics Stands With AnalystsBenzinga Insights - Dec 8, 2022, 10:03AM
- Piper Sandler Downgrades Fulgent Genetics to Neutral, Lowers Price Target to $40Benzinga Newsdesk - Dec 8, 2022, 5:14AM